Kubota Pharmaceutical Holdings Co., Ltd. (TYO:4596)

Japan flag Japan · Delayed Price · Currency is JPY
61.00
+5.00 (8.93%)
Jun 3, 2026, 3:30 PM JST
Market Cap6.46B +140.6%
Revenue (ttm)17.76M -39.6%
Net Income-729.42M
EPS-9.15
Shares Out 115.40M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,124,200
Open56.00
Previous Close56.00
Day's Range56.00 - 64.00
52-Week Range41.00 - 350.00
Beta1.85
Analystsn/a
Price Targetn/a
Earnings DateMay 14, 2026

About TYO:4596

Kubota Pharmaceutical Holdings Co., Ltd. engages in the pharmaceutical and medical device business worldwide. The company offers eyeMO, a remote retinal monitoring device for home-based and patient self-monitoring optical coherence tomography; and a NASA high-res version OCT device. It also provides Emixustat HCI compounds for Stargardt disease indications in Phase 3 clinical trials, as well as proliferative diabetic retinopathy and diabetic macular edema in Phase 2 clinical trials. The company was founded in 2002 and is headquartered in Minato... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2002
Employees 8
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4596
Full Company Profile

Financial Performance

In 2025, TYO:4596's revenue was 21.00 million, a decrease of -22.22% compared to the previous year's 27.00 million. Losses were -676.00 million, -49.25% less than in 2024.

Financial Statements